Gene Regulation Grants & Funding


Gene Regulation Grants & Funding - Research at Peter Mac

Current Grants and Funding
NHMRC Project Grant: $168,750 p.a, ‘Defining the apoptotic and therapeutic activities of histone deacetylase inhibitors’, R.W. Johnstone, 2009–11.

Prostate Cancer Foundation of Australia Concept Grant: $150,000 p.a, ‘Cell death and mobilizing immunity for the treatment of established prostate cancer’, R.W. Johnstone & M.J. Smyth. 2009-10.

Novartis Collaborative Research Grant: $183,000 p.a. ‘Determining the effects of panobinostat on platelet production and survival’. R.W. Johnstone, H.M. Prince, S. Harrison. 2009–10.

Victorian Cancer Agency Platform Technology Capacity Building Grant: $150,000 ‘Enhanced access to whole genome RNA interference screens through the Victorian Centre for Functional Genomics’. R.W Johnstone. 2009–10.

Australian Cancer Research Foundation: $2.5 million. ‘Establishment of the ACRF Cancer Genomics Program’. R.W. Johnstone, D. Bowtell, R. Hannan, G McArthur, P. Humbert, D. Thomas, K. Simpson, V. Marshall, 2009.

Victorian Breast Cancer Research Consortium (VBCRC) Translational Research Grant: $1,288,500, ‘Development and testing novel anti-breast cancer therapies’. R.W. Johnstone, M. Smyth, R. Hannan, R. Pearson, S. Loi. 2009–12.

NHMRC Program Grant: $2.16 Million p.a., ‘Immune regulation, effector function and therapy’, R.W Johnstone, D.I. Godfrey, H.M. Prince, M.J. Smyth & J.A. Trapani. 2007–12.

Susan G. Komen for the Cure Foundation (USA): $US200,000 p.a. 'Combination chemo-immunotherapy for established breast cancer', R.W. Johnstone, M. Smyth, 2008–10.

Pfizer Australia Senior Research Fellowship for Assoc. R.W. Johnstone: $200,000 p.a., 2005–10.

Cancer Research Institute (USA): $US450,000, 'Cancer Research Institute Pre-doctoral Emphasis Program in Tumour Immunology', R.W. Johnstone (Co-CI with MJ Smyth, J Trapani, D Godfrey, J McCluskey, W. Chen, A. Scott), 2008–11.

Cure Cancer Australia Foundation Project Grant: $74,000, 'To develop a new project investigating whether an in vivo model of CLL can be established and utilised for pre-clinical testing of HDACi and ABT-737 combination therapy,' A. Alsop, 2009.

Peter Mac Foundation Grant: $79,514, 'Continued development of the project aiming to establish an in vivo model of CLL and determine its utility for pre-clinical drug testing', A. Alsop, 2009.

NHMRC Biomedical Career Development Award: $92,500pa, V. Solomon, 2009–12.

Bioplatforms Access Voucher: $10,000, V. Solomon, 2009.

Dutch Cancer Society: €333,600, 'Molecular characterisation of therapeutics in hepatocellular carcinoma', M. Bots, 2009–13.



Printer friendly page

Links



Grants & Funding >
Publications & Patents >
Projects >
Achievements, Awards & Prizes >
Research Images >

Contact Details
+61 (0)3 9656 1238
ricky.johnstone@petermac.org

Research Personnel
Group Leader
Associate Professor Ricky Johnstone

Postdoctoral Fellows
Dr Amber Alsop
Dr Michael Bots
Dr Vanessa Solomon
Dr Geoff Matthews
Dr Michaela Waibel
Dr Ailsa Frew
Dr Inge Verbrugge


Technical Assistants
Kellie Banks
Leonie Cluse
Ben Martin
Rachael Ralli
Andrea Reitsma
Ashley Robertson
Kym Stanley


PhD Students
Dr Mark Bishton
Katrina Falkenberg
Nicole Messina
Andrea Newbold
Dr Jake Shortt
Alison West


Laboratory Manager
Jason Brady

Administrative Assistant
Belinda Kelly